NCT06504667

Brief Summary

The objective of the device feasibility study will be to validate the user needs of the Point Mini system. This study will be a single group intervention model where one group of 5 children with partial-hand upper limb loss will be asked to perform several tasks. Successful completion of a task results in a fulfilled user need. Failure to complete a task results in an unfulfilled user need.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jul 2025

Geographic Reach
1 country

2 active sites

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 10, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 17, 2024

Completed
1 year until next milestone

Study Start

First participant enrolled

July 29, 2025

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 29, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 29, 2025

Completed
Last Updated

December 17, 2025

Status Verified

December 1, 2025

Enrollment Period

Same day

First QC Date

July 10, 2024

Last Update Submit

December 11, 2025

Conditions

Outcome Measures

Primary Outcomes (10)

  • VAL-1

    User wears Point Mini(s) for a entire session without discomfort (Pass/Fail)

    Day 1 (8 hours)

  • VAL-2

    User flexes and extends the Point Mini(s) without using contralateral hand ten times (Pass/Fail)

    Day 1 (10 minutes)

  • VAL-3.1

    User lifts a 10-25 lb bag with Point Mini(s) depending on age (Pass/Fail)

    Day 1 (10 minutes)

  • VAL-3.2

    User grips a hammer with Point Mini(s) and makes indentations into the wood (Pass/Fail)

    Day 1 (10 minutes)

  • VAL-4

    User releases Point Mini(s) while performing an active grasp by pressing the dorsal button ten times sequentially (Pass/Fail)

    Day 1 (10 minutes)

  • VAL-5

    User positions Point Mini(s) into each of the locking positions without binding (Pass/Fail)

    Day 1 (10 minutes)

  • VAL-6

    User activates spring-back mechanism ten times without failure by using (1) contralateral hand, (2) tabletop, and (3) side or thigh (Pass/Fail)

    Day 1 (10 minutes)

  • VAL-7

    User grips a 5 lb cylindrical smooth object using Point Mini(s) for 10 seconds (Pass/Fail)

    Day 1 (10 minutes)

  • VAL-8

    User picks up 4 coins from a smooth tabletop within 30 seconds (Pass/Fail)

    Day 1 (10 minutes)

  • VAL-9

    User performs VAL-1 through VAL-8 without Point Mini releasing from mounting system (Pass/Fail)

    Day 1 (8 hours)

Study Arms (1)

Prosthesis

EXPERIMENTAL

Patient is temporarily fit with Point Mini finger prosthetic system

Device: Point Mini

Interventions

The Point Mini finger prosthetic system consists of 1-4 ratcheting mechanical digits and mounting brackets

Prosthesis

Eligibility Criteria

Age5 Years - 15 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Partial hand loss with at least index and/or middle fingers loss at the MCP level
  • Intact thumb with full range of motion
  • Fluent in English
  • Between the ages of 5 and 15 years

You may not qualify if:

  • Patients with a residual limb that is unhealed from the amputation surgery
  • Unhealed wounds
  • Significant cognitive deficits as determined upon clinical evaluation
  • Significant neurological deficits as determined upon clinical evaluation
  • Significant physical deficits of the residual limb impacting full participation in the study as determined upon clinical evaluation
  • Uncontrolled pain or phantom pain impacting full participation in the study as determined upon clinical evaluation
  • Serious uncontrolled medical problems as judged by the project therapist

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of Colorado Denver | Anschutz Medical Campus

Aurora, Colorado, 80045, United States

Location

Point Designs

Lafayette, Colorado, 80026, United States

Location

MeSH Terms

Conditions

Amputation, Congenital

Study Officials

  • Levin Sliker, PhD

    CEO, Point Designs

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DEVICE FEASIBILITY
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 10, 2024

First Posted

July 17, 2024

Study Start

July 29, 2025

Primary Completion

July 29, 2025

Study Completion

July 29, 2025

Last Updated

December 17, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations